Literature DB >> 22545423

Role of glutathione in cancer pathophysiology and therapeutic interventions.

Simendra Singh1, Amir R Khan, Alok K Gupta.   

Abstract

Glutathione (GSH) is an important intracellular antioxidant that instills several vital roles within a cell including maintenance of the redox state, drug detoxification, and cellular protection from damage by free radicals, peroxides and toxins. Molecular alterations in the components of the GSH system in various tumors can lead to increased survival and enhanced tumor drug resistance. Early identification of the importance of intracellular GSH to detoxification reactions has now led to investigating the potential importance that GSH chemistry has on signal transduction, molecular regulation of cellular physiology and regulation of apoptosis pathway. Several therapeutic agents that target this system have been developed and used experimentally and clinically in an attempt to improve cancer chemotherapy. This review highlights different roles played by GSH that finally regulate tumor growth and advances in the use of GSH-based drugs to specifically target this detoxifying system in cancer treatment as a means to increase therapeutic response and decrease chemotherapeutic drug resistance.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22545423

Source DB:  PubMed          Journal:  J Exp Ther Oncol        ISSN: 1359-4117


  33 in total

1.  Role of glutamate transporters in redox homeostasis of the brain.

Authors:  Stephanie M Robert; Toyin Ogunrinu-Babarinde; Kenneth T Holt; Harald Sontheimer
Journal:  Neurochem Int       Date:  2014-01-10       Impact factor: 3.921

2.  Altered glutamate cysteine ligase expression and activity in renal cell carcinoma.

Authors:  Monong Li; Zongliang Zhang; Jiangshui Yuan; Yanlun Zhang; Xunbo Jin
Journal:  Biomed Rep       Date:  2014-09-09

3.  Oxidized glutathione (GSSG) inhibits epithelial sodium channel activity in primary alveolar epithelial cells.

Authors:  Charles A Downs; Lisa Kreiner; Xing-Ming Zhao; Phi Trac; Nicholle M Johnson; Jason M Hansen; Lou Ann Brown; My N Helms
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-02-20       Impact factor: 5.464

4.  SLC7A11 expression is associated with seizures and predicts poor survival in patients with malignant glioma.

Authors:  Stephanie M Robert; Susan C Buckingham; Susan L Campbell; Stefanie Robel; Kenneth T Holt; Toyin Ogunrinu-Babarinde; Paula P Warren; David M White; Meredith A Reid; Jenny M Eschbacher; Michael E Berens; Adrienne C Lahti; Louis B Nabors; Harald Sontheimer
Journal:  Sci Transl Med       Date:  2015-05-27       Impact factor: 17.956

5.  Inhibition of melanoma development in the Nras((Q61K)) ::Ink4a(-/-) mouse model by the small molecule BI-69A11.

Authors:  Yongmei Feng; Eric Lau; Marzia Scortegagna; Chelsea Ruller; Surya K De; Elisa Barile; Stan Krajewski; Pedro Aza-Blanc; Roy Williams; Anthony B Pinkerton; Michael Jackson; Lynda Chin; Maurizio Pellecchia; Marcus Bosenberg; Ze'ev A Ronai
Journal:  Pigment Cell Melanoma Res       Date:  2012-11-02       Impact factor: 4.693

Review 6.  Glutamate transporters in the biology of malignant gliomas.

Authors:  Stephanie M Robert; Harald Sontheimer
Journal:  Cell Mol Life Sci       Date:  2013-11-27       Impact factor: 9.261

7.  A Landscape of Metabolic Variation across Tumor Types.

Authors:  Ed Reznik; Augustin Luna; Bülent Arman Aksoy; Eric Minwei Liu; Konnor La; Irina Ostrovnaya; Chad J Creighton; A Ari Hakimi; Chris Sander
Journal:  Cell Syst       Date:  2018-01-27       Impact factor: 10.304

Review 8.  Glutathione levels in human tumors.

Authors:  Michael P Gamcsik; Mohit S Kasibhatla; Stephanie D Teeter; O Michael Colvin
Journal:  Biomarkers       Date:  2012-08-20       Impact factor: 2.658

9.  Metabolism of cisplatin in the organs of Rattus norvegicus: role of Glutathione S-transferase P1.

Authors:  Ritika Nagar; Amir Riyaz Khan; Anuj Poonia; Pankaj Kishor Mishra; Simendra Singh
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2014-01-29       Impact factor: 2.441

10.  A highly GSH-sensitive SN-38 prodrug with an "OFF-to-ON" fluorescence switch as a bifunctional anticancer agent.

Authors:  Chang-Hee Whang; Eunsoo Yoo; Seong Kwon Hur; Kyeong Soo Kim; Dongin Kim; Seongbong Jo
Journal:  Chem Commun (Camb)       Date:  2018-07-26       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.